Discover how Dr. Amr Nairoukh, General Manager of Nairoukh Group and founder of Misk Pharma, is redefining the MENA pharmaceutical landscape. After a personal, life-altering health journey, he chose to bypass premium profit margins to register Jordan’s first generic Semaglutide—prioritizing patient relief over corporate profits. Learn how he leverages Jordan’s regulatory framework to connect the region with advanced South Korean biotechnology now.
